Hemoglobin A1c Testing Devices for Diabetes Market

Hemoglobin A1c Testing Devices for Diabetes Market contains market size and forecasts of Hemoglobin A1c Testing Devices for Diabetes in global, including the following market information:

Global Hemoglobin A1c Testing Devices for Diabetes Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hemoglobin A1c Testing Devices for Diabetes Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hemoglobin A1c Testing Devices for Diabetes companies in 2021 (%)

The global Hemoglobin A1c Testing Devices for Diabetes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Boronate Affinity Chromatography Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemoglobin A1c Testing Devices for Diabetes include Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Roche, Menarini Group and Sebia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hemoglobin A1c Testing Devices for Diabetes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemoglobin A1c Testing Devices for Diabetes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1c Testing Devices for Diabetes Market Segment Percentages, by Type, 2021 (%)

Boronate Affinity Chromatography

Direct Enzymatic Assay

Immunoassay

Ion-Exchange HPLC

Micro-Optical Detection Method

Capillary Electrophoresis

Global Hemoglobin A1c Testing Devices for Diabetes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1c Testing Devices for Diabetes Market Segment Percentages, by Application, 2021 (%)

Laboratory Testing Devices

Point-of-Care Testing Devices

Global Hemoglobin A1c Testing Devices for Diabetes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemoglobin A1c Testing Devices for Diabetes Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemoglobin A1c Testing Devices for Diabetes revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hemoglobin A1c Testing Devices for Diabetes revenues share in global market, 2021 (%)

Key companies Hemoglobin A1c Testing Devices for Diabetes sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Hemoglobin A1c Testing Devices for Diabetes sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

ARKRAY

Bio-Rad

PTS Diagnostics

Beckman Coulter

EKF Diagnostics

Roche

Menarini Group

Sebia

Siemens Healthcare

Tosoh

Trinity Biotech

Danaher Corporation

A. Menarini Diagnostics

HUMAN Diagnostics

OSANG Healthcare